Watchlist

Watchlist
Ampio Pharmaceuticals, Inc. (AMPE)
Ampio Pharmaceuticals, Inc. (AMPE)
Ampio Updates Scientific presentations and publications on Ampion(TM)
ENGLEWOOD, Colo. , May 22, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a poster presentation on the mechanism of action of a component of Ampion will be presented at AAST and the most recent study of Ampion treatment of Severe Osteoarthri…
Warrant You Glad You're Not Long Ampio?
Editor's note: Seeking Alpha is proud to welcome Tau Equity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Edito…
Ampio Provides Corporate Update
ENGLEWOOD, Colo. , May 14, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), a developer of novel therapeutics to address significant inflammatory conditions for which limited treatment options exist, today announced updates to shareholders that address questions rec…
The Pivotal Trial Results on Ampion(TM) (AP-003-C) Was Accepted for Publication in a Peer-Reviewed Medical Journal
ENGLEWOOD, Colo. , May 2, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the publication entitled: "Intra-articular injection of the anti-inflammatory compound LMWF-5A (Ampion) in adults with severe osteoarthritis: a double-blind prospe…
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data
A nalysis focus: Intercept Intercept Pharmaceuticals ( ICPT ) reported clinical data from a liver biopsy-based substudy from its phase 3 POISE study. The study indicated that long-term OCA treatment in patients with PBC led to reversal or stabilization of fibrosis and cirrhosis. …
The Battle For Ampio Pharmaceuticals Reaches Inflection Point As Shorts Run Out Of Gas
Ampio Pharmaceuticals (NASDAQ: AMPE ) has made it clear to Wall Street that the company is up for sale. In a recent ad hoc twitter poll the most likely suitor to buy AMPE is Merck (NYSE: MRK ) with 36% of the vote followed by Johnson and Johnson (NYSE: JNJ ) with 32%, Pfizer(NYSE: PFE ) with…
Ampio updates regulatory, clinical and NYSE activities
Ampio Pharmaceuticals (NASDAQ: AMPE ) has begun preliminary discussions with the FDA on details of the Biologics License Application (BLA) submission process for Ampion, a treatment for severe osteoarthritis-of-the-knee. More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, …
Ampio Updates Regulatory, Clinical and NYSE Activities
ENGLEWOOD, Colo. , April 12, 2018 /PRNewswire/ --Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announces the Company has begun preliminary discussions with the Food and Drug Administration on details of the Biologics License Application (BLA) submission process for Ampion&#x212…
Ampio Pharmaceuticals: Cash Critically Low, Pattern Of Exaggerated Claims Continues
Ampio Pharmaceuticals ( AMPE ) stock is trading near its highest levels of the year with an enterprise value of approximately $330m despite poor prospects of its sole drug in development and a very low probability of an economically attractive partnership or buyout. The last reported net cash …
Midday Gainers / Losers (04/10/2018)
Gainers: PAY +52% . KONE +47% . CNET +35% . SPPI +31% . TNDM +20% . PIXY +16% . OSN +15% . SYNL +13% . NEWA +13% . JRJC +13% . More news on: VeriFone Systems, Inc., Kingtone Wirelessinfo Solution Holding Ltd, ChinaNet Online Holdings, Inc., Stocks on the mo…
Ampio Pharmaceuticals, Inc. (AMPE)